Carter Robertson

[Carter Robertson @cahtarrobs]

@ArtsStocks @Mcdivot06 @BiopharmIQ @biospace Just look at SP. market is telling you what company is better. Don’t need you regurgitating analyst comments

[Carter Robertson @cahtarrobs]

@TTRAmyloid @Mcdivot06 Guy is just sad he picked the wrong horse. He even went as far to say “short ARWR” when it was at $70. Being wrong is ok if you admit it. This is just sad

[Carter Robertson @cahtarrobs]

@3IDWarrant They should have kept it based on last 2 trading days…

[Carter Robertson @cahtarrobs]

@jim_miller64 Where you getting heading back to 3B?

[Carter Robertson @cahtarrobs]

@Longroaderstar They are not. Elizabeth C room.

[Mystical Fortunes 🔮 @MFTarotCardRdr]

City of Edmonton voting process is a microcosm of how it runs the whole city. A joke. Slow. Five stations by the time you are finished. I’ve never seen such long line ups. No bloody wonder they get low voter turnout. This needs to be fixed.

[Carter Robertson @cahtarrobs]

@sonichedgefund Same for $ARWR

[Carter Robertson @cahtarrobs]

@SuperDuperDrugs @PikaCapital Still plenty of wholly owned opportunities

[Carter Robertson @cahtarrobs]

@lafforug If so why is ARWR flat now that SRPT seems to be out of the woods with FDA

[Carter Robertson @cahtarrobs]

@jfais20 Trading flat while $SRPT up 30%
Make that make sense pls

[Carter Robertson @cahtarrobs]

@PikaCapital +25% vs +0.8% you guess which is which

[Pika Capital @PikaCapital]

$ARWR should be trading at least 10-15% up after hours based on the $SRPR news. But market is a joke of course

[Carter Robertson @cahtarrobs]

$SRPT we are going to focus on RNAI and the $ARWR partnership. $SRPT +25%

$ARWR +0.8%

Make it make sense

[Carter Robertson @cahtarrobs]

@SuperDuperDrugs Nothing on RAGE?

[Carter Robertson @cahtarrobs]

@MaxoluIbikunle @Pharmdca Oh I’m long the stock going on 10yrs but mgmt has done zero damage control. It’s trading at 2018 levels less than 2B mkt cap. If mgmt is making 10s of millions are they not to be held accountable?

[Carter Robertson @cahtarrobs]

@MaxoluIbikunle @Pharmdca High CEO salary, executive compensation structure just gives shares. Zero open market buys amidst share price plummet. Worst IR in biotech

[Carter Robertson @cahtarrobs]

@MaxoluIbikunle @Pharmdca MGMT holding company back. Need a change at the helm badly

[Carter Robertson @cahtarrobs]

@3IDWarrant 1.65B up front would be 90% of current mkt cap. LLY better off taking whole co.

[Carter Robertson @cahtarrobs]

@3IDWarrant @ArrowheadPharma @Alnylam Voting results tomorrow? Any expectations?

[Carter Robertson @cahtarrobs]

@paulBIOgeek @ArrowheadPharma @Alnylam Spread even bigger today. This makes sense now